Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creative Value Capital is an investment entity organized as an Israeli limited partnership rather than a biotechnology, pharmaceutical, or healthcare operating company. Public references identify it primarily in the context of shareholder activism, including board nomination activity involving ReWalk Robotics/Lifeward. There is no evidence that Creative Value Capital develops therapeutic products, runs a drug pipeline, or offers life sciences R&D services. Based on available public information, it appears to function as an investment vehicle focused on capital deployment and shareholder-value initiatives rather than as a healthcare business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creative Value Capital.